1256808-59-9 Usage
Uses
Used in Medicinal Chemistry:
5-Fluoro-3-methylpicolinic acid is used as a building block for the synthesis of various biologically active molecules and pharmaceutical drugs. Its chemical structure and properties make it a valuable tool for creating new potential drug candidates with improved pharmacological and therapeutic properties.
Used in Pharmaceutical Research:
In the field of pharmaceutical research, 5-Fluoro-3-methylpicolinic acid is utilized for the development of new drugs with enhanced efficacy and safety profiles. Its unique structure allows for the exploration of novel therapeutic agents that can address unmet medical needs.
Used in Disease Treatment:
5-Fluoro-3-methylpicolinic acid has been studied for its potential application in the treatment of various diseases and disorders. Its versatility and chemical properties make it a promising candidate for the development of targeted therapies and interventions in medicine and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1256808-59-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,8,0 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1256808-59:
(9*1)+(8*2)+(7*5)+(6*6)+(5*8)+(4*0)+(3*8)+(2*5)+(1*9)=179
179 % 10 = 9
So 1256808-59-9 is a valid CAS Registry Number.
1256808-59-9Relevant academic research and scientific papers
OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
-
Page/Page column 97, (2012/07/28)
The invention relates to novel heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free form or in pharmaceutically acceptable salt form, to their preparation, to their medical use and to medicaments comprising them.
2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS
-
Page/Page column 172, (2011/11/30)
This invention relates to compounds of the formula (I), wherein A, B and R1 to R7 are as described below, or to pharmaceutically acceptable salts thereof. These compounds are BACE1 and/or BACE2 inhibitors and can be used as 5 medicam
2,5,6,7-TETRAHYDRO-[1,4]OXAZEPIN-3-YLAMINE OR 2,3,6,7-TETRAHYDRO-[1,4]OXAZEPIN-5-YLAMINE COMPOUNDS
-
Page/Page column 82, (2012/01/13)
This invention relates to compounds of the formula wherein A, B and R1 to R7 are as described below, or to pharmaceutically acceptable salts thereof. These compounds are BACE1 and/or BACE2 inhibitors and can be used as medicaments fo
